TransMedics to Present at the Cowen 40th Annual Health Care Conference

ANDOVER, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming Cowen 40th Annual Health Care Conference in Boston.

TransMedics’ management is scheduled to present on Tuesday, March 3, 2020 at 8:40 a.m. Eastern Time. A live and archived webcast of the event will be available on the “Investors” section of the TransMedics website at www.transmedics.com. 

About TransMedics Group, Inc.

TransMedics is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Investor Contact:Brian Johnston631-807-1986[email protected]

You May Also Be Interested In

• Micware Group Reorganization Finalized
• Prosafe SE: Second-quarter results and first half report 2026
• OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026